Combining Cholesterol Drugs Proves To Be Dangerous
Millions of Americans take medications to lower their cholesterol, but one such medication was taken off the market a few years ago after it led to a muscle disorder in those taking it.
Johnson &amp; Johnson will delay by five months the release of a study comparing its Cypher heart device with Boston Scientific Corp.'s Taxus, the first large-scale comparison of the only two drug-coated stents on the market.